NEW YORK--(BUSINESS WIRE)--Sept. 14, 2006--Antigenics Inc. (NASDAQ: AGEN) today announced the appointment of Hyam I. Levitsky, MD, to its board of directors. Currently a professor of oncology, medicine and urology at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, the scientific director of Johns Hopkins' George Santos Bone Marrow Transplant Program, and a member of the Cancer Vaccine Consortium's executive council, Dr. Levitsky's appointment brings more than 15 years of clinical and research experience to Antigenics' board of directors.
